• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Renal elimination kinetics and plasma half-life of oxalate in man.

作者信息

Osswald H, Hautmann R

出版信息

Urol Int. 1979;34(6):440-50. doi: 10.1159/000280294.

DOI:10.1159/000280294
PMID:494445
Abstract

The renal handling of oxalate was studied by the injection of 14C-oxalate together with inulin as a glomerular marker into the renal artery in 6 patients. From the recovered amounts of the injected substances in the urine, time-concentration curves were constructed. Oxalate was excreted into urine 2.31 +/- 0.05 (SE) fold when compared to inulin. The maximal concentration of oxalate occurred at the same time as inulin, and there was no urinary precession of oxalate in comparison to inulin. From this part of the study we conclude that oxalate in addition to its filtered amount can probably enter the early part of nephron. In a second type of study, plasma levels of oxalate and inulin were observed over a period of 180 min, following intravenous injections in 7 volunteers. The decline of oxalate plasma concentrations followed first-order kinetics. Calculation of the rate constants of elimination assuming the 'one compartment open' model resulted in an oxalate to inulin ratio of 1.21 +/- 0.05. The oxalate half-life of elimination was 92 +/- 8 min, whereas that of inulin amounted to 112 +/- 9 min. The higher value of the calculated volume of distribution of oxalate compared to that of inulin indicates that oxalate enters a larger space than the extracellular fluid volume. The urinary recovery of intravenously injected oxalate was 97.2 +/- 1.4%, indicating that oxalate is excreted exclusively by the kidney. The observed differences of oxalate excretion, obtained with these two methods, could be attributed to the higher amount of ionized oxalate in the disequilibrium technique (rapid injections), entering the urine in a higher rate. Such a mechanism could explain the hyperoxaluria in calcium oxalate stone-forming patients.

摘要

相似文献

1
Renal elimination kinetics and plasma half-life of oxalate in man.
Urol Int. 1979;34(6):440-50. doi: 10.1159/000280294.
2
Pharmacokinetic studies of oxalate in man.
Invest Urol. 1979 Mar;16(5):395-8.
3
Renal clearance of [14C]oxalate: comparison of constant-infusion with single-injection techniques.
Clin Sci (Lond). 1982 Jul;63(1):47-51. doi: 10.1042/cs0630047.
4
Fate of circulating oxalate in rats.大鼠体内循环草酸盐的去向
Eur Urol. 1993;23(4):485-9. doi: 10.1159/000474659.
5
An isotopic study of oxalate excretion in sheep.绵羊草酸盐排泄的同位素研究。
Aust J Exp Biol Med Sci. 1975 Dec;53(6):479-87. doi: 10.1038/icb.1975.53.
6
[Pharmacokinetic study on oxalate in rats].[大鼠体内草酸盐的药代动力学研究]
Hinyokika Kiyo. 1988 Jul;34(7):1135-40.
7
Oxalate metabolism in renal stone disease with special reference to calcium metabolism and intestinal absorption.肾结石病中的草酸盐代谢,特别涉及钙代谢和肠道吸收。
Scand J Urol Nephrol Suppl. 1989;119:1-53.
8
Plasma oxalate concentration and oxalate distribution volume in patients with normal and decreased renal function.
Eur J Clin Invest. 1985 Feb;15(1):45-9. doi: 10.1111/j.1365-2362.1985.tb00142.x.
9
The urinary response to an oral oxalate load in recurrent calcium stone formers.复发性草酸钙结石患者口服草酸盐负荷后的尿液反应。
J Urol. 2003 Jun;169(6):2030-3. doi: 10.1097/01.ju.0000062527.37579.49.
10
Renal handling of oxalate. A micropuncture study in the rat.草酸盐的肾脏处理。大鼠的微穿刺研究。
Naunyn Schmiedebergs Arch Pharmacol. 1978 Oct;304(3):277-81. doi: 10.1007/BF00507969.

引用本文的文献

1
Determinants of Kidney Failure in Primary Hyperoxaluria Type 1: Findings of the European Hyperoxaluria Consortium.1型原发性高草酸尿症肾衰竭的决定因素:欧洲高草酸尿症联盟的研究结果
Kidney Int Rep. 2023 Aug 4;8(10):2029-2042. doi: 10.1016/j.ekir.2023.07.025. eCollection 2023 Oct.
2
Oxalate (dys)Metabolism: Person-to-Person Variability, Kidney and Cardiometabolic Toxicity.草酸盐(代谢)紊乱:人与人之间的差异、肾和代谢相关心脏毒性。
Genes (Basel). 2023 Aug 29;14(9):1719. doi: 10.3390/genes14091719.
3
Lumasiran in the Management of Patients with Primary Hyperoxaluria Type 1: From Bench to Bedside.
鲁马西拉治疗1型原发性高草酸尿症患者:从实验室到临床应用
Int J Nephrol Renovasc Dis. 2022 Jun 17;15:197-206. doi: 10.2147/IJNRD.S293682. eCollection 2022.
4
Physiological and Pathological Functions of SLC26A6.SLC26A6的生理和病理功能
Front Med (Lausanne). 2021 Jan 21;7:618256. doi: 10.3389/fmed.2020.618256. eCollection 2020.
5
Contribution of Dietary Oxalate and Oxalate Precursors to Urinary Oxalate Excretion.膳食草酸盐和草酸盐前体对尿草酸盐排泄的贡献。
Nutrients. 2020 Dec 28;13(1):62. doi: 10.3390/nu13010062.
6
Dietary Oxalate Intake and Kidney Outcomes.饮食草酸盐摄入量与肾脏结局。
Nutrients. 2020 Sep 2;12(9):2673. doi: 10.3390/nu12092673.
7
Correlation between the molecular effects of mutations at the dimer interface of alanine-glyoxylate aminotransferase leading to primary hyperoxaluria type I and the cellular response to vitamin B.导致 I 型原发性高草酸尿症的丙氨酰-乙醛酸氨基转移酶二聚体界面突变的分子效应与维生素 B 细胞反应之间的相关性。
J Inherit Metab Dis. 2018 Mar;41(2):263-275. doi: 10.1007/s10545-017-0105-8. Epub 2017 Nov 6.
8
The role of intestinal oxalate transport in hyperoxaluria and the formation of kidney stones in animals and man.肠道草酸盐转运在动物和人类高草酸尿症及肾结石形成中的作用。
Urolithiasis. 2017 Feb;45(1):89-108. doi: 10.1007/s00240-016-0952-z. Epub 2016 Dec 2.
9
N-acetylcysteine protects against star fruit-induced acute kidney injury.N-乙酰半胱氨酸可预防杨桃诱导的急性肾损伤。
Ren Fail. 2017 Nov;39(1):193-202. doi: 10.1080/0886022X.2016.1256315. Epub 2016 Nov 15.
10
Primary and secondary hyperoxaluria: Understanding the enigma.原发性和继发性高草酸尿症:解读谜团。
World J Nephrol. 2015 May 6;4(2):235-44. doi: 10.5527/wjn.v4.i2.235.